Home / Conditions / Rhinitis
Rhinitis: when insurers say no, reviewers often say yes
In 14 published external-review decisions involving rhinitis, independent physician reviewers overturned the insurer’s denial 42.9% of the time.
Published decisions
14
2001–2026
Overturned
42.9%
6 denials reversed
Most-fought treatments for rhinitis
What insurers denied — and how those fights ended.
| Category | Decisions | Overturned |
|---|---|---|
| Sinus Surgery | 5 | 80% |
What the insurer actually argued
Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
| Reason given | Decisions | Overturned |
|---|---|---|
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 9 | 44.4% |
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 5 | 40% |
Typical time to a decision
21 days
Most land between 17 and 21 days
Handled as urgent
14.3%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for (1) radiofrequency ablation of the posterior nasal nerve area and/or (2) low-dose radiofrequency intranasal tissue remodeling of the nose. Chronic rhinitis is an inflammatory condition of the nasal cavity, which typically manifests as nasal obstruction and excessive nasal discharge. It can be triggered by allergic stimuli, non-allergic stimuli, or a combination of the two. Standard medical therapies for chronic rhinitis include intranasal corticosteroids, intranasal antihistamines, and intranasal anticholinergics. For cases recalcitrant to medical therapy, surgical options include inferior turbinate reduction, Vidian neurectomy, and posterior nasal neurectomy.
Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for sinus surgery (nasal/sinus endoscopy, surgical, with destruction by cryoablation, posterior nasal nerve (PNN) and/or nasal/sinus endoscopy, surgical with destruction by radiofrequency ablation, posterior nerve with the approved septoplasty). The records reflect that the patient suffered from vasomotor rhinitis, also known as non-allergic rhinitis, as well as allergic rhinitis. Symptoms of both include rhinorrhea, postnasal drip, nasal obstruction, which are thought to occur from autonomic nerve dysregulation particularly in the case of vasomotor rhinitis.
Where the denial was upheld
Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for an allergy skin test. Seidman and colleagues explain that allergic rhinitis is one of the most common disease affecting adults. Clinical practice guidelines report that a diagnosis of allergic rhinitis begins with a directed history and physical examination particularly noting pattern, chronicity, and triggers of symptoms. In this case, the patient has symptoms of intermittent cough, shortness of breath, scratchy throat, and postnasal drip. The records document prior treatment with allergy shots directed by a prior positive skin test, and allergies to tree pollen, weed pollen, dust, and dog dander. The patient had been off all medications since completing allergy shots in 2015.
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for ClariFix procedure bilateral cryoablation to the mucosal surface. As noted in a comprehensive practice parameter for allergic rhinitis and nonallergic rhinitis developed jointly by the researchers, first-line therapy for both persistent allergic and non-allergic rhinitis includes intranasal antihistamine and/or intranasal corticosteroids. Additionally, the authors found that intranasal antihistamine and intranasal corticosteroid dual therapy is significantly better than intranasal corticosteroid alone in alleviating nasal and ocular symptoms in patients with allergic rhinitis. In a systematic review, an academic study found that cryoablation was effective in reducing symptoms associated with chronic rhinitis.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
How to use this in your appeal
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for rhinitis was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.